Keutzer Timothy Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
5
Insider Sells Sum
$97,855.85

Insider Activity of Keutzer Timothy

According to the SEC Form 4 filings, Keutzer Timothy, being in a position of

  1. Chief Operating Officer at Spero Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 65238 shares for $145,193,
    over all time since 2023-02-02, has bought 0 shares, and sold 161902 shares for $246,388.

Biography of Keutzer Timothy

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $145,1934100

Comparison of Insiders on Amount of Buys and Sells

2026-02-06SaleSpero Therapeutics, Inc.
SPRO
Chief Operating Officer
18,652
0.0323%
$2.36$44,019-9.3%
2026-02-04SaleSpero Therapeutics, Inc.
SPRO
Chief Operating Officer
3,471
0.006%
$2.24$7,775-3.71%
2026-02-03SaleSpero Therapeutics, Inc.
SPRO
Chief Operating Officer
24,224
0.043%
$2.14$51,839+3.27%
2026-02-02SaleSpero Therapeutics, Inc.
SPRO
Chief Operating Officer
18,891
0.0332%
$2.20$41,560-1.12%
2025-08-28SaleSpero Therapeutics, Inc.
SPRO
Chief Operating Officer
1,695
0.003%
$1.97$3,339+16.5%
2025-02-05SaleSpero Therapeutics, Inc.
SPRO
Chief Operating Officer
56,537
0.1074%
$0.78$44,099+150.86%
2024-08-27SaleSpero Therapeutics, Inc.
SPRO
Chief Operating Officer
2,213
0.004%
$1.35$2,988-15.58%
2024-02-02SaleSpero Therapeutics, Inc.
SPRO
Chief Operating Officer
30,971
0.0506%
$1.36$42,121-8.22%
2023-08-28SaleSpero Therapeutics, Inc.
SPRO
Chief Development Officer
1,854
0.0035%
$1.26$2,336+11.51%
2023-02-02SaleSpero Therapeutics, Inc.
SPRO
Chief Operating Officer
3,394
0.0066%
$1.86$6,313-20.77%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.